Enhanced low density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy

The American Journal of Cardiology

Volumn 75, Issue 1, 1995, Pages 34-39

  Schrott, Helmut G ^a,b,c,d,e   Stein, Evan A ^a,b,c,d,e   Dujovne, Carlos A ^a,b,c,d,e   Davidson, Michael H ^a,b,c,d,e   Goris, George B ^a,b,c,d,e   Oliphant, Thomas H ^a,b,c,d,e   Phillips, Joann C ^a,b,c,d,e   Shawaryn, Gregory G ^a,b,c,d,e  

^a UNIVERSITY OF IOWA   (United States)

^b CHRIST HOSPITAL   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d RADIANT RESEARCH   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; COLESTIPOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIET RESTRICTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN;

APOLIPOPROTEINS; CHOLESTEROL, LDL; COLESTIPOL; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS; LOVASTATIN; MALE; MIDDLE AGED;

EID: 0028873411     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80523-2     Document Type: Article

References (25)

1. The Lipid Research Clinics Coronary Primary Prevention Trial Results
2. Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
3. Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
4. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
5. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens
6. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
7. Expanded Clinical Evaluation of Lovastatin (EXCEL) Study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia
8. Management of hypercholesterolemia
9. The dietary R.I.S.C. rating: a novel method to assess the hyperlipidemic potential of a diet
10. Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the hpid clinics' methodology
11. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
12. The Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements
13. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.
14. Development and evaluation of a competitive enzyme-linked immunoabsorbent assay of Lp(a)
15. Differential electroimmunoassay of human Lp A-I lipoprotein particles on ready-to-use plates
16. The treatment of refractory hyperlipoproteinemia
17. The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins in familial hypercholesterolemia
18. SIMVASTATIN (MK 733): AN EFFECTIVE TREATMENT FOR HYPERCHOLESTEROLEMIA
19. Long-term maintenance of therapeutic response to lovastatin in patients with familial and nonfamilial hypercholesterolemia: a 3-year follow-up
20. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia: effects on kinetics of apolipoprotein B
21. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride
22. Lovastatin alone and in combination for treatment of primary hypercholesterolemia
23. Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia
24. Comparative Efficacy and Safety of Pravastatin and Cholestyramine Alone and Combined in Patients With Hypercholesterolemia
25. Low-density lipoprotein subclass patterns and risk of myocardial infarction